Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Amphetamine sulfate cost?

See the DrugPatentWatch profile for Amphetamine

The cost of amphetamine sulfate can vary depending on several factors, including the dosage, the specific product formulation, and whether it is a generic or brand-name prescription. Prices can range significantly.

How Much Does Generic Amphetamine Sulfate Typically Cost?


Generic versions of amphetamine sulfate are generally more affordable than brand-name options. For instance, a prescription for a 30-day supply of immediate-release amphetamine sulfate, at a common dosage, might range from approximately $20 to $50 without insurance. Extended-release formulations or higher dosages could increase this cost.

What Influences the Price of Amphetamine Sulfate?


Several elements affect the final price of amphetamine sulfate. These include:

* Dosage Strength: Higher milligrams per dose typically translate to a higher overall cost.
* Formulation: Immediate-release tablets are often less expensive than extended-release capsules or liquid suspensions.
* Manufacturer: Different generic manufacturers may have slightly different pricing structures.
* Pharmacy: Retail prices can differ between pharmacies, even for the same medication. Discount programs or pharmacy chains might offer lower prices.
* Insurance Coverage: Prescription drug insurance plans significantly impact out-of-pocket expenses. Co-pays, deductibles, and whether the medication is on the plan's formulary (list of covered drugs) are key determinants. Without insurance, the cost is the full retail price.

Can I Get Amphetamine Sulfate Cheaper with Insurance?


Yes, insurance coverage can substantially reduce the cost of amphetamine sulfate. Most insurance plans cover generic medications, including amphetamine sulfate, with a co-payment that is typically much lower than the full retail price. The exact co-pay amount depends on the specific insurance plan. It is advisable to check with your insurance provider or pharmacy to understand your coverage and estimated out-of-pocket cost.

Are There Ways to Lower the Cost of Amphetamine Sulfate?


Patients looking to reduce their spending on amphetamine sulfate may consider several options:

* Generic Options: Always opt for the generic version unless specifically directed otherwise by a healthcare provider.
* Discount Cards and Coupons: Many pharmacies and third-party websites offer discount cards or coupons that can provide savings on prescription medications.
* Pharmacy Choice: Compare prices at different pharmacies, as they can vary. Larger chain pharmacies or independent pharmacies may offer competitive pricing.
* Mail-Order Pharmacies: Some insurance plans or discount programs include mail-order pharmacy options, which can sometimes offer cost savings for maintenance medications.
* Patient Assistance Programs: If facing significant financial hardship, inquire with the manufacturer or patient advocacy groups about potential assistance programs.

What About Brand-Name vs. Generic Amphetamine Sulfate Pricing?


Brand-name amphetamine sulfate, such as Adderall (which contains mixed amphetamine salts, including amphetamine sulfate), is generally more expensive than its generic counterparts. When patents expire and generic versions become available, prices typically decrease due to increased competition. For example, a 30-day supply of brand-name Adderall could cost upwards of $150-$300 or more without insurance, whereas generic amphetamine sulfate would be considerably less.

When Did Generic Amphetamine Sulfate Become Available?


The availability of generic versions of amphetamine sulfate depends on the specific brand-name drug and its patent status. For widely prescribed medications like those containing amphetamine salts, generic versions have been available for some time, contributing to broader accessibility and affordability. Information on specific patent expiries and the introduction of generics for various amphetamine-based medications can be found on resources like DrugPatentWatch.com [1].

What are the Risks of Taking Amphetamine Sulfate?


Amphetamine sulfate is a stimulant medication with potential side effects and risks. Common side effects can include decreased appetite, dry mouth, difficulty sleeping, and increased heart rate. More serious risks, though less common, can involve cardiovascular problems, psychiatric issues (such as hallucinations or mania), and the potential for dependence or addiction, especially with misuse. It is crucial to take this medication exactly as prescribed by a healthcare professional and to discuss any concerns about side effects or risks.

What Other Medications are Similar to Amphetamine Sulfate?


Other stimulant medications used to treat conditions like ADHD share similar mechanisms of action. These include methylphenidate (found in Ritalin and Concerta) and lisdexamfetamine (Vyvanse). Non-stimulant medications, such as atomoxetine (Strattera), are also used as alternatives. The choice of medication depends on individual patient needs, response to treatment, and tolerability of side effects.

How is Amphetamine Sulfate Regulated?


Amphetamine sulfate is classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA). This classification indicates that the drug has a high potential for abuse and dependence. As such, its prescribing, dispensing, and manufacturing are subject to strict federal and state regulations to prevent diversion and misuse.

---
Sources

1. DrugPatentWatch.com. (n.d.). Retrieved from https://www.drugpatentwatch.com/



Other Questions About Amphetamine :

What is amphetamine sulfate? Amphetamine drug price? Amphetamine salts er 5 mg cap? Amphetamine cost? Amphetamine er cost? Amphetamine sulfate price? Amphetamine salt combo xr cost?

AI-Drug Label Prescribing Information Alignment Report

28
28%
Grade D

Poor

Not Aligned

Patient Risk: Medium

Summary

Only a generic alignment with common abuse/misuse warnings is assessable, but the provided content includes unverifiable or potentially mis-specified label citations and does not provide enough label text to confirm exact wording/completeness for the specific claim set. Many non-label-related statements are cost/side-effect/general guidance and cannot be verified against the supplied prescribing information excerpts.


Category Scores

Warnings
35
Poor
AdverseReactions
25
Poor

Accurate Statements

Amphetamine sulfate is a stimulant medication.
Amphetamine sulfate has a high potential for abuse and misuse, which can lead to dependence or addiction, especially with misuse.
Label excerpt provided states DYANAVEL XR has a high potential for abuse and misuse which can lead to substance use disorder/addiction (Sections 5.1 and 9.2).
Misuse/abuse of CNS stimulants can result in overdose and death, with risk increased by higher doses or unapproved methods of administration such as snorting or injection.
Label excerpt provided: overdose/death with increased risk with higher doses or unapproved methods such as snorting/injection (Sections 5.1 and 9.2).

Unsupported Statements

The cost of amphetamine sulfate can vary depending on dosage, product formulation, and whether it is generic or brand-name.
No cost/distribution/price information is present in the supplied prescribing information excerpts.
Generic versions of amphetamine sulfate are generally more affordable than brand-name options.
No pricing/insurance/coupon statements are supported by the supplied prescribing information excerpts.
A 30-day supply of immediate-release amphetamine sulfate at a common dosage might range from approximately $20 to $50 without insurance.
No quantitative pricing is present in the supplied prescribing information excerpts.
Extended-release formulations or higher dosages could increase the cost.
No cost relationships are supported by the supplied prescribing information excerpts.
Immediate-release tablets are often less expensive than extended-release capsules or liquid suspensions.
No pricing/formulation comparisons are supported by the supplied prescribing information excerpts.
Prescription drug insurance plans significantly impact out-of-pocket expenses; co-pays, deductibles, formulary status affect out-of-pocket cost; without insurance, the cost is the full retail price; most insurance plans cover generic medications, including amphetamine sulfate...
No insurance coverage/cost-sharing statements are present in the supplied prescribing information excerpts.
Amphetamine sulfate should be taken exactly as prescribed.
This is general counseling not contained in the supplied abuse/misuse/addiction excerpt.
Amphetamine sulfate prescribing, dispensing, and manufacturing are subject to strict federal and state regulations to prevent diversion and misuse.
No such regulatory manufacturing/dispensing statements are included in the supplied prescribing information excerpts.
Amphetamine sulfate is classified as a Schedule II controlled substance by the U.S. DEA. Schedule II classification indicates the drug has a high potential for abuse and dependence.
DEA Schedule language is not included in the supplied prescribing information excerpts.
Common side effects ... decreased appetite, dry mouth, difficulty sleeping, and increased heart rate.
The supplied label excerpts do not list these as side effects/adverse reactions.
More serious risks ... cardiovascular problems; psychiatric issues such as hallucinations or mania.
While hallucinations are mentioned in overdose effects in the supplied excerpt, the broader “cardiovascular problems” and “mania” statements are not explicitly supported by the supplied excerpts.
Patient assistance programs may be available for those facing significant financial hardship, through the manufacturer or patient advocacy groups.
No patient assistance program statements are present in the supplied prescribing information excerpts.
Brand-name amphetamine sulfate (e.g., Adderall...) is generally more expensive than generic counterparts.
No pricing/brand comparison is present in the supplied prescribing information excerpts.
When patents expire and generic versions become available, prices typically decrease due to increased competition.
No pricing/patent-to-price discussion is present in the supplied prescribing information excerpts.
The availability of generic versions ... depends on the specific brand-name drug and its patent status.
No generic availability/patent status discussion is present in the supplied prescribing information excerpts.

Contradictions

Low

AI Statement
Schedule II classification indicates the drug has a high potential for abuse and dependence.

Label Reference
Not contradicted by provided excerpts; however, the specific DEA Schedule II statement is not present in the supplied label excerpts, so contradiction cannot be assessed. No direct contradiction is identifiable from provided content.


Important Omissions

Any FDA-label-supported administration/dosing details for DYANAVEL XR (e.g., dose, titration, missed dose guidance) are omitted.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Medium
The response includes multiple unsupported or non-label-specific claims (especially cost/coverage and general side-effect lists). Only the abuse/misuse and overdose-risk concepts align with the supplied excerpts; however, insufficient label-backed detail increases the chance of inaccuracy in safety-relevant counseling content.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Many statements are not supported by the supplied FDA prescribing information excerpts (pricing/insurance/coupons/patient assistance and general side-effect lists). Only partial alignment exists with abuse/misuse/addiction and overdose-risk warnings.

Suggested Improvement
Limit safety claims to those explicitly present in the provided label excerpts (abuse/misuse/addiction risk; overdose/death; risk increased with higher doses/unapproved administration). Remove unsupported cost/insurance/coupon and generic/brand pricing statements, and avoid listing side effects unless they are contained in the supplied label text.

Drug Brand Mention Assessment

Branding Score
63
Visibility
67
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

Schedule II controlled substance


Core Claims
  • Generic versions of amphetamine sulfate are generally more affordable than brand-name options.
  • Insurance coverage can substantially reduce the cost of amphetamine sulfate.
  • Patients looking to reduce their spending... may consider several options.
  • Amphetamine sulfate is a stimulant medication with potential side effects and risks.
  • Amphetamine sulfate is classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA).
Differentiators
  • Brand-name amphetamine sulfate (e.g., Adderall) is generally more expensive than generics.
  • Exact cost depends on dosage, formulation, and whether it is generic or brand-name.
  • Availability of generics depends on the specific brand-name drug and its patent status.

Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Adderall 31%
50 #2 No
Ritalin 29%
50 #8 No
Concerta 29%
50 #8 No
Vyvanse 29%
50 #8 No
Strattera 29%
50 #8 No